Avalo Therapeutics, Inc. (AVTX) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
1500 LIBERTY RIDGE DRIVE WAYNE, PA 19087 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 134,546 | 7,415 | 13,172 | 54,585 | 18,919 | 11,238 | |||
| Cash and cash equivalent | 134,546 | 7,415 | 13,172 | 54,585 | 18,919 | 3,609 | |||
| Short-term investments | 7,629 | ||||||||
| Other undisclosed cash, cash equivalents, and short-term investments | |||||||||
| Restricted cash and investments | 19 | 1 | 15 | 51 | 38 | 18 | |||
| Receivables | 611 | 136 | 1,919 | 3,739 | 2,208 | 4,241 | |||
| Inventory, net of allowances, customer advances and progress billings | 20 | 38 | 3 | 21 | |||||
| Inventory | 20 | 38 | 3 | 21 | |||||
| Disposal group, including discontinued operation | 498 | ||||||||
| Other undisclosed current assets | 3,714 | 843 | 1,290 | 3,432 | 4,837 | 1,709 | |||
| Total current assets: | 138,890 | 8,395 | 16,416 | 61,845 | 26,005 | 17,724 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 741 | 1,329 | 1,750 | 2,001 | 917 | 719 | |||
| Intangible assets, net (including goodwill) | 10,502 | 10,502 | 14,409 | 14,447 | 15,994 | 16,835 | |||
| Goodwill | 10,502 | 10,502 | 14,409 | 14,409 | 14,409 | 14,409 | |||
| Intangible assets, net (excluding goodwill) | 38 | 1,585 | 2,426 | ||||||
| Restricted cash and investments | 131 | 131 | 131 | 227 | 149 | 102 | |||
| Disposal group, including discontinued operation, noncurrent assets | 1,000 | ||||||||
| Other undisclosed noncurrent assets | 468 | 636 | 661 | 694 | 690 | 729 | |||
| Total noncurrent assets: | 11,842 | 12,598 | 16,951 | 18,369 | 17,750 | 18,385 | |||
| TOTAL ASSETS: | 150,732 | 20,993 | 33,367 | 80,214 | 43,755 | 36,109 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3,493 | 1,026 | 5,581 | 7,790 | 5,724 | 4,341 | |||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 552 | ||||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 4,310 | 3,119 | 1,592 | ||
| Accounts payable | 283 | 446 | 2,882 | 3,369 | 2,574 | 2,078 | |||
| Accrued liabilities | 3,210 | 580 | 2,699 | 111 | 31 | 120 | |||
| Debt | 5,930 | 156 | |||||||
| Derivative instruments and hedges, liabilities | 360 | ||||||||
| Disposal group, including discontinued operation | 1,342 | 3,891 | |||||||
| Other undisclosed current liabilities | 3,107 | 3,592 | 10,603 | 12,098 | 8,160 | 3,772 | |||
| Total current liabilities: | 6,960 | 4,618 | 22,114 | 19,888 | 15,225 | 12,160 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 13,486 | 32,833 | 1,038 | ||||||
| Long-term debt, excluding current maturities | 13,486 | 32,833 | |||||||
| Liabilities, other than long-term debt | 9,090 | 8,437 | 8,393 | 2,411 | 1,969 | 2,953 | |||
| Deferred income tax liabilities | 270 | 155 | 141 | 113 | 90 | 86 | |||
| Disposal group, including discontinued operation, liabilities | 1,755 | ||||||||
| Other liabilities | 350 | 1,366 | 1,711 | 2,298 | 1,878 | 1,112 | |||
| Operating lease, liability | 350 | 1,366 | 1,711 | 1,038 | |||||
| Derivative instruments and hedges, liabilities | 8,120 | 5,550 | 4,830 | ||||||
| Other undisclosed noncurrent liabilities | 1,650 | 634 | 289 | 2,000 | 962 | ||||
| Total noncurrent liabilities: | 10,740 | 9,071 | 22,168 | 37,244 | 3,969 | 2,953 | |||
| Total liabilities: | 17,700 | 13,689 | 44,282 | 57,132 | 19,194 | 15,113 | |||
| Equity | |||||||||
| Equity, attributable to parent | 133,032 | 7,304 | (10,915) | 23,082 | 24,562 | 20,996 | |||
| Preferred stock | 1 | 3 | |||||||
| Common stock | 10 | 1 | 9 | 113 | 75 | 44 | |||
| Additional paid in capital | 503,285 | 342,437 | 292,900 | 285,135 | 202,276 | 135,239 | |||
| Accumulated other comprehensive income | |||||||||
| Accumulated deficit | (370,263) | (335,134) | (303,824) | (262,166) | (177,790) | (114,291) | |||
| Total equity: | 133,032 | 7,304 | (10,915) | 23,082 | 24,562 | 20,996 | |||
| TOTAL LIABILITIES AND EQUITY: | 150,732 | 20,993 | 33,367 | 80,214 | 43,755 | 36,109 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 441 | 1,924 | 18,051 | 5,398 | 6,699 | 6,750 | ||
| Cost of revenue | (27,584) | (1,284) | (3,434) | (1,492) | (300) | |||
| Cost of product and service sold | (1,284) | (3,434) | (1,491) | (300) | ||||
| Gross profit: | (27,143) | 640 | 14,617 | 3,906 | 6,398 | 6,750 | ||
| Operating expenses | (41,369) | (27,991) | (52,057) | (86,040) | (79,241) | (23,371) | ||
| Other undisclosed operating income | 484 | |||||||
| Operating loss: | (68,512) | (27,351) | (37,440) | (82,134) | (72,843) | (16,137) | ||
| Nonoperating income (expense) | 33,497 | (4,179) | (4,190) | (2,411) | 5,667 | 147 | ||
| Other nonoperating income (expense) | (5) | (42) | (20) | (20) | 410 | (24) | ||
| Loss from continuing operations before income taxes: | (35,015) | (31,530) | (41,630) | (84,545) | (67,177) | (15,990) | ||
| Income tax expense (benefit) | (114) | (14) | (28) | 196 | 2,793 | (280) | ||
| Other undisclosed loss from continuing operations | ||||||||
| Loss from continuing operations: | (35,129) | (31,544) | (41,658) | (84,349) | (64,384) | (16,271) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (84,349) | (64,384) | (16,271) | |
| Net loss: | (35,129) | (31,544) | (41,658) | (84,349) | (64,384) | (16,271) | ||
| Other undisclosed net income (loss) attributable to parent | (27) | 884 | 198 | |||||
| Net loss attributable to parent: | (35,129) | (31,544) | (41,658) | (84,376) | (63,500) | (16,073) | ||
| Other undisclosed net income available to common stockholders, basic | ||||||||
| Net loss available to common stockholders, basic: | (35,129) | (31,544) | (41,658) | (84,376) | (63,500) | (16,073) | ||
| Other undisclosed net income (loss) available to common stockholders, diluted | (121,611) | |||||||
| Net loss available to common stockholders, diluted: | (156,740) | (31,544) | (41,658) | (84,376) | (63,500) | (16,073) | ||
Comprehensive Income ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (35,129) | (31,544) | (41,658) | (84,349) | (64,384) | (16,271) | ||
| Comprehensive loss: | (35,129) | (31,544) | (41,658) | (84,349) | (64,384) | (16,271) | ||
| Other undisclosed comprehensive income, net of tax, attributable to parent | ||||||||
| Comprehensive loss, net of tax, attributable to parent: | (35,129) | (31,544) | (41,658) | (84,349) | (64,384) | (16,271) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.